CGS 10746B: An atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses
- 1 August 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 39 (8), 699-705
- https://doi.org/10.1016/0024-3205(86)90017-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Clozapine—A serotonin antagonist?Pharmacology Biochemistry and Behavior, 1984
- Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake ratsNeuropharmacology, 1984
- Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations and species differencesPeptides, 1983
- Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neuronsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1983
- Estimation of the Turnover of 3‐Methoxytyramine in the Rat Striatum by HPLC with Electrochemical Detection: Implications for the Sequence in the Cerebral Metabolism of DopamineJournal of Neurochemistry, 1982
- Dr. Snyder RepliesAmerican Journal of Psychiatry, 1981
- 3-methoxytyramine and different neuroleptics: Dissociation from HVA and DOPACLife Sciences, 1978
- Climbing behaviour induced by apomorphine in mice: A potential model for the detection of neuroleptic activityEuropean Journal of Pharmacology, 1978
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974
- Tardive Dyskinesia and Drug Therapy in Geriatric PatientsArchives of General Psychiatry, 1974